Cartesian Therapeutics, Inc. Logo

Cartesian Therapeutics, Inc.

A clinical-stage company developing mRNA-engineered cell therapies for autoimmune diseases.

RNAC | US

Overview

Corporate Details

ISIN(s):
US8162121045
LEI:
Country:
United States of America
Address:
7495 NEW HORIZON WAY, 21703 FREDERICK

Description

Cartesian Therapeutics, Inc. is a clinical-stage company that pioneers the development of mRNA-engineered cell therapies. The company's primary focus is on creating treatments for autoimmune diseases. Leveraging its novel mRNA technology platform, Cartesian develops therapeutic cells designed to target the drivers of these conditions. This approach aims to expand the reach and potential of cell therapy for patients with various autoimmune disorders. The company's lead asset, Descartes-08, is a central component of its clinical pipeline.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-08-07 13:05
8-K
English ZIP 2.1 MB
2025-06-16 13:06
8-K
English ZIP 57.8 KB
2025-05-30 13:02
8-K
English ZIP 2.1 MB
2025-05-14 22:15
FORM 4
English ZIP 7.6 KB
2025-05-08 13:13
S-8
English ZIP 50.5 KB
2025-05-08 13:05
10-Q
English ZIP 2.0 MB
2025-05-08 13:04
8-K
English ZIP 2.1 MB
2025-04-29 14:01
8-K
English ZIP 67.6 KB
2025-04-28 22:42
DEF 14A
English ZIP 6.8 MB
2025-04-28 22:41
DEFA14A
English ZIP 1.1 MB
2025-04-16 22:35
FORM 4
English ZIP 7.6 KB
2025-04-11 23:29
FORM 4
English ZIP 8.2 KB
2025-04-08 13:04
8-K
English ZIP 5.9 MB
2025-03-21 00:50
FORM 4
English ZIP 7.8 KB
2025-03-13 12:06
10-K
English ZIP 7.7 MB

Automate Your Workflow. Get a real-time feed of all Cartesian Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Cartesian Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Cartesian Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.